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Amyloid-beta (Aβ) pathology is related to mitochondrial dysfunction accompanied by energy reduction and an elevated
production of reactive oxygen species (ROS). Monomers and oligomers of Aβ have been found inside mitochondria where
they accumulate in a time-dependent manner as demonstrated in transgenic mice and in Alzheimer’s disease (AD) brain. We
hypothesize that the internalization of extracellular Aβ aggregates is the major cause of mitochondrial damage and here we report
that following the injection of ﬁbrillar Aβ into the hippocampus, there is severe axonal damage which is accompanied by the
entrance of Aβ into the cell. Thereafter, Aβ appears in mitochondria where it is linked to alterations in the ionic gradient across the
innermitochondrialmembrane.Thiseﬀectisaccompaniedbydisruptionofsubcellularstructure,oxidativestress,andasigniﬁcant
reduction in both the respiratory control ratio and in the hydrolytic activity of ATPase. Orally administrated melatonin reduced
oxidative stress, improved the mitochondrial respiratory control ratio, and ameliorated the energy imbalance.
1.Introduction
Theintracellularaccumulationofhighlyamyloidogenic1–42
residue amyloid-beta peptide (Aβ1–42)m a yr e s u l tf r o m ,( a )
decreasedAβ degradationduetodisruptionoftheubiquitin-
proteasome system, (b) increased intracellular generation of
Aβ, or (c) increased uptake of Aβ from an external source [1,
2]. The internalization of Aβ1–42 peptide by primary neurons
is related to a lipid raft-mediated endocytosis [2]. These lipid
rafts are dynamic assemblies of proteins and lipids ﬂoating
freely within the liquid-disordered bilayer of cellular mem-
branes where cholesterol and sphingomyelin play key roles
[3]. Reciprocally, cholesterol and sphingomyelin metabolism
are strongly related to Aβ [4]. In fact, there are clues indi-
cating that Aβ levels change in response to blood cholesterol
content, while the clinical progression of Alzheimer’s disease
(AD) is commonly associated to hypercholesterolemia and
high cholesterol levels in the brain [5, 6].
Another factor gaining more relevance as a mechanism
of neuronal damage is oxidative stress, which is a hallmark2 Oxidative Medicine and Cellular Longevity
feature of Aβ-induced brain damage in AD [7], AD trans-
genic mice [8], as well as in in vitro and other in vivo models
of this neurodegenerative condition [9, 10]. Mitochondrial
dysfunction and associated oxidant stress have been linked
to numerous complex diseases and aging [11, 12], such asso-
ciation has been largely established by in vitro determination
of mitochondrial free radicals overproduction. Membrane-
associated oxidative stress in turn has been linked to lipid
alterations [13], and the exposure of hippocampal neurons
to Aβ, in vitro, induces oxidative damage to membranes,
accompanied by accumulation of sphingomyelin-derived
ceramide species and cholesterol [14]. In fact, by preventing
the accumulation of ceramides and cholesterol it is possible
toprotectneuronsfromdeathinducedbyAβ;thisisachieved
with an antioxidant like α-tocopherol or by depleting
hippocampal neurons of its sphingomyelin content with
an inhibitor of serine palmitoyltransferase, the rate-limiting
step in sphingolipid synthesis [15]. Focal demyelination of
the cortical grey matter as well as of dystrophic neurites
has been observed in AD patients and transgenic mice
associated to Aβ plaque core [16]. Thus, it is possible that
the breakdown of myelin promotes the buildup of toxic Aβ
ﬁbrils, which eventually accumulate in the brain [17].
There is evidence, on the other hand, that the amyloid
precursor protein (APP) and Aβ accumulate in mitochon-
drial membranes, as observed in postmortem AD or in
transgenic mice brain sections [18–20]. Aβ extracellularly
applied to human neuroblastoma SH-SY5Y cells was found
to be internalized and be taken up by mitochondria by using
the transporter outer membrane (TOM) [21]. Most of the
imported Aβ1–42 appeared associated to the inner membrane
and only a small fraction was localized to the matrix.
We hypothesized that due to its amphipathic nature
[22], its physicochemical composition [23], and being aided
by oxidative stress [10, 24], Aβ paves its own pathway
from extracellular space to mitochondria where it disrupts
membrane ﬂuidity and causes energetic dysfunction. This
mechanism of membrane permeabilization induced by Aβ
and its own internalization might be the major cause of
mitochondrial dysfunction.
Since oxidative stress is considered a key factor in
these pathogenic mechanisms, melatonin should reduce the
dysfunctional manifestations of Aβ uptake [25]. Melatonin
is a proven antioxidant [26, 27], especially in the brain
where it reduces molecular damage as demonstrated in
animal models of AD [28, 29], as well as in other exper-
imental models of neurodegeneration [30–33]. There are
two important clues regarding the role of melatonin in
mitochondriarescue,(1)melatoninpenetratesmitochondria
where it scavenges free radicals [34, 35], (2) melatonin
directly inhibits mitochondrial permeability transition pore
(MtPTP) [36].
To further document these potential protective eﬀects of
melatonin, we worked in vivo by injecting ﬁbrillar Aβ1–42
directly into hippocampal CA1 pyramidal neurons layer.
Aged Wistar rats used in these experiments had no other
condition or genetic predisposition to form plaques or other
AD features.
2. Results
2.1. Axonal Damage in fAβ Injected Rats. The most striking
abnormal change was the intramural accumulation, adhe-
sion, and formation of Aβ aggregates in the myelinated
axons.Thus,Aβ invadedtheconcentricmultilamellarmyelin
sheath of the axon (oligodendrocyte cytoplasm). These
Aβ aggregates caused dissection and disruption of myelin
layers with mural vacuolization, forming onion bulb-like
protuberances as found in chronic neuropathies [37]. In
some cases, all layers were disrupted and positive Aβ-
immunoreactivity extending from the interstitium to the
axonal lumen was observed (Figure 1). Within the onion
bulb-like protuberances, Aβ appeared to form aggregates;
once inside the axons and mitochondria, the Aβ aggregates
were disintegrated, adopting a granular appearance.
2.2. Cholesterol-Enriched Diet in Aβ- I n j e c t e dR a t sI sR e l a t e d
to a Signiﬁcant Increase in Mitochondrial Membrane Damage.
Animals fed with regular Laboratory Rodent Diet showed
a normal cholesterol level in blood. When these animals
were intracerebrally injected with Aβ showed not only
signiﬁcantly less degree of mitochondrial structural damage
as compared to Aβ-injected but also hypercholesterolemic
animals due to a cholesterol-enriched diet, as observed by
electron microscopy (Figure 2).
2.3. Intracerebrally Injected fAβ 1–42 Causes Extracellular
Aggregates, Axonal Degeneration, and Accumulates in Mito-
chondria. Thirty-six hours following the intracerebral injec-
tion of f Aβ1–42, brain tissue was obtained and subjected
to conventional and transmission electron microscopic
examination. Using a polyclonal antibody against Aβ for
immunohistochemistry, extracellulardeposits ofthis peptide
accompanied by an intense microglial response (data not
shown) were revealed, as expected (Figure 3(a)). 70–90nm
ultrathin brain sections were incubated with the same anti-
Aβ primary antibody, followed by incubation with a gold-
labeled secondary antibody. The observation by electron
microscopy revealed Aβ immunoreactivity inside mitochon-
dria (Figure 3(b)), accompanied by important swelling,
rupture of the outer membrane and cristae dissolution
(Figures 3(b) and 3(c)). Aβ was found localized to the cristae
of the inner membrane of mitochondria. Both in H2O2-a n d
in fAβ-injected brains signiﬁcant ultrastructural alterations
were observed. H2O2 was chosen as a positive control
of oxidative stress, because of its well-known pathogenic
relationshipwithAβ(reviewedin[38]).Themostprominent
change was the peripheral vacuolization of the cristae,
as shown in Figure 3. Vacuolization in mitochondria was
accompanied by electrodense Aβ-immunoreactivity with
inclusions being grouped and bound to the membranes,
particularly to the inner cristae membranes. Rupture of
the membranes resulted in discontinuity and formation
of gaps. Mitochondria looked swollen with disorganized
membrane structures and the cristae were lost. In some
localized areas, the intermembranous space was absent and
the mitochondrion appeared like an irregularly enlarged,
single-membrane sac (Figure 3(c)).Oxidative Medicine and Cellular Longevity 3
(a) (b)
(c) (d)
Figure 1: Aβ-induced axonal damage. Following the intracerebral injection of fAβ into the hippocampus, small blocks of tissue brain
containing the lesion area were postﬁxed in osmium tetroxide 2%, embedded for 48 hours in Embed 812, cut into 70–90nm ultrathin
sections, and then subjected to immunohistochemical procedures using an anti-Aβ antibody. Binding sites of the primary antibody were
thenrevealedbyincubatingwithagold-labeledsecondaryantibody.Finally,sectionswerecounterstainedwithuranylacetateandleadcitrate
and observed in an electron microscope. (a) Amyloid tangles within the concentric layers of myelin sheath of axons (white arrows) and a
widening of the myelin sheath, corresponding to accumulations of Aβ from a primary pole, are observed. Electrodense spots sparse within
the axon (black arrowheads), also seem to enter into the lumen from the primary pole (white arrowhead) (16,700x). (b) Aβ electrodense
spots penetrating into the axons from widening onion bulb-like structures (white arrows) (10,000x). (c) Onion bulb detail (35,750x)
showing abundant electrodense material corresponding to gold revealed Aβ (white arrow) and the detachment zone (black arrow). Amyloid
tangles seem to be granulated once crossing the myelin sheath (black arrowheads). (d) Myelin sheath as observed in PBS-injected rat brain
(magniﬁcation at 2156x).
2.4. The Incorporation of Intracerebrally Injected Aβ into
Mitochondria Is Related to Mitochondrial Free Radical Over-
production. Brainsectionswer eobtainedfr omeachgr oupt o
determine mitochondrial mass density by using Mitotracker
Green FM, a selective ﬂuorescent dye whose mitochondria
localization is independent of the membrane potential.
Mitochondria from PBS-injected brains showed uniform
box-like shapes regularly distributed and ranging in size
from 318 to 1832nm (mean 964 ± 365nm) with an average
integrated optical density (IOD) of 41.7 ± 3.5 (Figures 4(a)
and 4(b)). In Aβ-injected brains, mitochondria was found
to form perinuclear clusters with a size ranging from 529 to
7400nm (mean 2812 ±1742nm, IOD = 54.5 ±4.6) (Figures
4(c) and 4(d)). Similar clusters were observed in H2O2-
injected rats (P<0.05), and they reached a size up to 23μm
(Figures 4(e) and 4(f)).
InordertocorrelatethepresenceofAβ withinmitochon-
dria and overproduction of free radicals by mitochondria, 36
hoursfollowingtheapplicationoffAβ1–42 and2hoursbefore
obtaining the tissue sample, CM-H2XRos, a chloromethyl
derivative of dihydro-X-rosamine, was intraperitoneally
injected; CM-H2XRos is a potential-dependent probe which
evaluates the direct production of mitochondrial reactive
oxygen species (ROS) in cells. Red CM-H2XRos dye has the
ability of diﬀusing into living cells, labeling only actively
respiring mitochondria [39] and it is well retained after
ﬁxation. Once located within cells, the reduced CM-H2XRos
is oxidized by ROS to a ﬂuorescent mitochondrion-sensitive
probe and sequestered in this organelle; thus, its oxidation is
useful to detect both ROS (predominantly superoxide anion,
O2
•−) and possibly reactive nitrogen species (nitric oxide,
•NO, and peroxynitrite, ONOO−). By comparing the IOD4 Oxidative Medicine and Cellular Longevity
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Figure 2: A cholesterol-enriched diet was signiﬁcantly related to a
more important loss of the mitochondrial integrity in animals. The
graph shows diﬀerences among PBS-injected brains from animals
receiving a regular laboratory rodent diet and two other groups of
amyloid-injected brains. These latter were from animals receiving a
normal diet and from animals receiving a cholesterol-enriched diet.
Amyloid-injected brains showed signiﬁcant loss of mitochondrial
membrane integrity as compared to PBS-injected brains. However,
those animals additionally fed with a cholesterol-enriched diet were
signiﬁcantly more aﬀected.
of randomly selected regions of equal size within a single
optical section, multiplied by the number of CM-H2XRos-
stained mitochondria, the overproduction of ROS for each
group was estimated. Thus, fAβ-injected brains showed
a signiﬁcant ROS overproduction, as expected (graph in
Figure 4).
2.5. Melatonin Signiﬁcantly Reduces ROS Overproduction.
Orally administered (20mg/kg/day added to the drinking
water), melatonin reached 145 ± 8pg/mLinserumbetween
01:00 and 02:00h, which was 84% higher than controls (data
not shown). At this dose, melatonin reduced signiﬁcantly
mitochondrial ROS overproduction, as graphically repre-
sented in Figure 5. Thus, IOD levels by mitochondrial CM-
H2XRos in fAβ1–42-injected brains diminished 35% in rats
taking melatonin in the drinking water, whereas in H2O2
intracerebrally injected rats, melatonin treatment reduced
an average of ROS levels by 69% as compared with H2O2
intracerebrally injected rats without melatonin treatment
(Figure 5).
Finally, by obtaining the quotient between ROS, esti-
mated by CM-H2XRos, and mitochondrial mass, estimated
by Mitotracker green caption, the apparently greater ability
of fAβ1–42 to cause oxidative damage with respect to H2O2
(graph in Figure 4), was reduced to its basal value (Figure 5).
The ability of melatonin to reduce free radicals was signiﬁ-
cant in both experimental groups.
2.6. Amyloid-Beta Depresses Both the Respiratory Control
Ratio and the ATPase Activity. 36 hours following the
intracerebral injection of fAβ1–42,w ef o u n dA β positive
immunoreactivity in mitochondria, which was closely asso-
ciated to mitochondrial damage and ROS overproduction, as
describedabove.Mitochondria werethenisolatedinorderto
examine a possible correlation between the mentioned ﬁnd-
ings with functional indicators, such as the mitochondrial
respiratory control ratio (RCR) and the hydrolysis activity of
F1Fo-ATPase. The former measures mitochondria ability to
idleatalowrateyetrespondtoADPbymakingATPatahigh
rate [40] in such a manner that is feasible to infer the leaking
of electron transfer without concomitant phosphorylation,
or how much ATP-synthase is partially uncoupled from
respiration; the latter, as a measure of the capacity to main-
tain an inner-membrane potential by coupling the energy
of the electrochemical proton gradient with ATP synthesis
[41]. A signiﬁcant diﬀerence was obtained comparing PBS-
injected (3.8 ± 0.03) and fAβ groups (2.6 ± 0.05) (P<
0.05). This diﬀerence was signiﬁcantly reduced when fAβ-
injected animals ingested melatonin in the drinking water
(fAβ / =fAβ +M e l ,P<0.05) (Figure 6).
H2O2-injected brains, used as positive controls, showed
a more signiﬁcant reduction in RCR (2.18 ± 0.06), and also
responded to melatonin treatment (Figures 8 and 9).
Interestingly, both fAβ and H2O2 reduced ATPase
hydrolytic activity but, contrary to the RCR response, mela-
tonin did not ameliorate this parameter (fAβ = fAβ +M e l )
(Figure 7).
In general, the more extensive oxidative damage was
related to the lower the respiratory control ratio and the
lower the ATPase hydrolytic activity (Figure 8).
2.7. There Is a Direct Correlation between Oxidative Stress-
InducedLowMembraneFluidityandaLowRCR. Afterestab-
lishing a link between the presence of Aβ in mitochondrion
and functional disturbances in this organelle, we searched
for changes in membrane ﬂuidity. This parameter correlates
with the degree of altered membrane lipid composition and
it is a well-known pathogenic factor directly aﬀecting the
energetic coupling of Ca2+ pumping, with the consequent
energetic failure. We found indeed, that following the
intracerebral injection of fAβ and its appearance inside
mitochondria, a signiﬁcant reduction in membrane ﬂuidity
was evident as compared to control Ie/Im ﬂuorescence
values (fAβ 2.6 ± 0.05 versus PBS-injected controls 3.5 ±
0.03, P<0.001). Brains of animals receiving melatonin
treatment showed a signiﬁcant recovery (fAβ 2.6 ± 0.05
versus fAβ +M e l2 .95 ± 0.05, P<0.001) (Figure 9).
3. Discussion
Considerable experimental data favor the hypothesis that
amyloid deposition in the brain is one of the etiolog-
ical factors contributing to AD dementia [43] and the
hypothesis of the “intracellular cascade of Aβ” has gained
preponderance [18]. It has been demonstrated that Aβ1–42
uncouples the mitochondrial respiratory chain and this
plays a key role in Alzheimer’s pathology [44]. Structurally,
Aβ induces swelling of isolated mitochondria [45, 46]a n d
functionally decreases ATP synthesis and the activity of
various mitochondrial enzymes, as demonstrated in vivo
[47]a n din vitro in cultured neuronal cells or in astrocytesOxidative Medicine and Cellular Longevity 5
Figure 3: Aβ in mitochondria, particularly on cristae of the inner membrane accompanied by severe disruption of the organelle. (a)
Deposits of Aβ aggregates into the hippocampal adjacent cortex 36 hours after injection, as shown by DAB-revealed horseradish peroxidase
immunohistochemistry (40x). Congophilic amyloid deposits remained visible up to 21 days following the intracerebral injection (data not
shown). (b) Aβ immunoreactivity (white arrows) within mitochondria 36 hours following the injection of fAβ1–42 into hippocampus CA1
pyramidal neurons at 35000x magniﬁcation. The same anti-Aβ polyclonal antibody used in the regular immunohistochemistry was used
in this procedure but revealed with a 6nm gold-labeled second antibody. Swollen mitochondria with broken cristae and its remnants
intermixed with ﬁne electron-dense dusty granule is observed. Additionally, the membrane integrity is lost and some vacuoles became
evident (black arrows). (c) Highly swollen mitochondria without cristae, like enlarged sacs, containing ﬁne electrodense granules, rupture of
external mitochondrial membranes (white arrow head), and vacuolization. In this case the anti-Aβ antibody was revealed with an irrelevant
secondary antibody, used as control. (d) Intact mitochondrial ultrastructure of a PBS-injected control rat (37000x).
exposed to the peptide [45, 47, 48]. Thus, Aβ-induced
mitochondrial damage may be an extension of the amyloid
cascade hypothesis, which 20 years ago suggested that the
altered metabolism of APP was the initiating event in AD
pathogenesis, subsequently leading to the aggregation of
Aβ,s p e c i ﬁ c a l l yA β1–42 [43, 49]. Later, diﬀerent neurotoxic
mechanisms for Aβ were proposed, including disruption
of mitochondrial function via binding of the Aβ-binding
alcoholdehydrogenase(ABAD)protein[19],orformationof
ionchannelsallowing calciumuptake whichinducesneuritic
abnormalities in a dose- and time-dependent fashion [50],
or the opening of the mitochondrial permeability transition
pore coupled to inhibition of respiratory complexes [51, 52].
A common underlying factor is the overactivation of
microglia with the consequent overexpression of proin-
ﬂammatory cytokines and a signiﬁcant increase in ROS,
which always prevails [53–56]. ROS, in turn, may come
from an innate immune response promoted by damaging
signals [55, 57] or they may come from the damaged
mitochondria [58]. This latter implies a pathological vicious
cycle, where mitochondrial dysfunction and ROS leakage
from the respiratory chain feed each other. However, there
is a pertinent question, is the mitochondrial impairment
a consequence of intraneuronal deposits of endogenous
oligomeric species of Aβ? Or are the extracellular deposits
of fAβ capable of reaching mitochondria, causing their
deterioration before the appearance of plaques?
APP has been localized to the trans-Golgi network,
endoplasmicreticulum(ER),andendosomal,lysosomal,and
mitochondrial membranes. Thus, the liberation of Aβ and
formation of intracellular accumulations could potentially
occur wherever APP and the β-a n dγ-secretases are local-
ized, which is particularly true when APP is overexpressed
(reviewed in [59]); this was not the case for the animals
used in the current experimentation. The data presented
here, obtained from aged Wistar rat brains, demonstrate that
mitochondria undergo major structural and physiological
changes following the intracerebral injection of fAβ1–42,
which in turn led to the formation of extracellular deposits
which eventually appeared in mitochondria.
Mitochondrial genes seem to be activated before plaque
formation, in addition to an increase in H2O2 content,
accompanied by a decrease in cytochrome oxidase activity, as
demonstrated in young Tg2576 mice prior to the appearance
of Aβ plaques [20]. It is not clear whether a soluble, intrami-
tochondrially produced Aβ could cause impairment of the
electron transport chain since, according to the theoretical
disposition of APP within the mitochondrial membrane
[60], Aβ would have to be imported from outside the
mitochondria, from the cytosol. This phenomenon has been
revealed and involves the translocase of the outer membrane
(TOM)andthetranslocaseoftheinnermembrane(TIM),as
shown in human cortical brain tissue specimens by Hansson
Petersen et al. [21].
However, Aβ has the ability by itself to permeabi-
lize membranes. Without discarding that Aβ from the
cytosol may invade mitochondria, it is worth to con-
sider the huge amounts of extracellular Aβ, forming
plaques outside the neurons, even visible to conventional
light microscopy. Aβ peptides are amphipathic molecules,6 Oxidative Medicine and Cellular Longevity
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Figure 4: The presence of Aβ within mitochondria is related to ROS overproduction. Control brain exhibited a regular distribution of
mitochondria (a) with a size of 964 ± 365nm, according to Mitotracker Green staining, which is essentially nonﬂuorescent in aqueous
solutions but becomes ﬂuorescent as it accumulates in the mitochondrial membranes. Nuclei appear in blue, stained with DAPI. The
amount of mitochondrial ROS in control PBS-injected brain was negligible, as inferred from CM-H2XRos staining, which speciﬁcally
accumulates inside mitochondria because of the positive charge it acquires upon oxidation by intracellular ROS (b). CM-H2XRos was
intraperitoneally injected in vivo 2 hours before obtaining the tissue sample. fAβ-injected brains showed a diﬀerent distribution of
mitochondria, predominantly perinuclear, ranging in size from 529 to 7400nm and forming clusters (c), (d). Integrated optical density
(IOD) of CM-H2XRos-stained mitochondria was signiﬁcantly (P<0.001) elevated in fAβ- and H2O2-injected brains (e), as compared with
controls (d), (f). In order to estimate how many mitochondria from the mitochondrial mass were overproducing ROS, we divide the IOD of
MT-Green by IOD of CM-H2XRos for each group, and we found a signiﬁcant diﬀerence between fAβ-injected brains and controls as shown
in the attached graphic (P<0.001).Oxidative Medicine and Cellular Longevity 7
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Figure 5: Melatonin reduces signiﬁcantly mitochondrial ROS overproduction. As expected, melatonin reduced the ﬂuorescence derived
from CM-H2XRos oxidation in both the fAβ-a n dt h eH 2O2-injected brains. According to Figure 4 most of the mitochondria in brains
injected with Aβ or H2O2 were producing free radicals. Now, by comparing the intensity of free radicals produced in brain of animals
receiving melatonin treatment against those animals without melatonin, a very signiﬁcant decrease in the amount of produced free radicals
was observed, as shown in the graph.
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Figure 6: Aβ-induced mitochondrial dysfunction. In order to
correlate both the presence of Aβ within mitochondria and the
overproduction of ROS with functional alterations in mitochon-
dria, oxygen consumption in isolated mitochondria (1mg/mL) was
measured using a Clark-type oxygen electrode at 34◦C in treatment
buﬀer, adding succinate as substrate. The respiratory control ratio
[state 3 rate] :[state 4 rate], as an indicator of the appropriate
coupling between respiration and phosphorylation, revealed a
signiﬁcant decrease in fAβ- and H2O2-injected brains, as compared
to controls (P<0.001). However, a signiﬁcant improvement in the
RCR was observed in animals treated with melatonin (P<0.05).
containing a hydrophilic N-terminal stretch (residues 1–
28) and a hydrophobic C-terminal domain (residues 29–
40/42) partially spanning the APP transmembrane domain.
In solution, Aβ peptides display a substantially unfolded
conformation with reduced content of secondary structure;
however, the latter increases considerably in phospholipid
vesicles particularly when enriched in cholesterol and gan-
gliosides[61, 62]. The ability of Aβ to insert into membranes
depends more on the cholesterol: phospholipid ratio. By
using the same experimental design as in this report, we
have found important evidence on Aβ-induced alterations
in the lipid content of mitochondrial membranes, in part
related possibly to a direct Aβ molecular interaction and
in part related to Aβ-induced oxidative stress (unpublished
data). Oxidative stress, on the other hand, may induce
membrane permeabilization by itself, as revealed by neutron
reﬂectometryinlipidbilayers[63],whereasagingisrelatedto
changes in the cholesterol, sphingomyelin, and phospholipid
content in membranes [61, 64, 65]. Thus, according to our
hypothesis, all these factors are concentrated to facilitate Aβ
entry into the cell and eventually to the mitochondria.
In fact, a preferential adsorption, internalization, and
resistance to degradation of the major isoform of the Aβ
peptide, Aβ1–42, has been shown in diﬀerentiated PC12 cells.
The amount of peptide internalized increases proportionally
with the concentration of peptide in the medium and the
amount of internalized Aβ1–42 is approximately 5-fold higher
than the amount of Aβ1–40 [66].
Aβ, extracellularly applied to human neuroblastoma
SH-SY5Y cells, was demonstrated to be internalized and
taken up by mitochondria [21]. In other experiments in
vivo, ﬂuorescence in isothiocyanate- (FITC-) labeled Aβ1–42
introduced via tail vein injection into mice with a blood
brain barrier (BBB) rendered permeable by treatment with
pertussis toxin, readily crossed the permeabilized BBB and
48 hours later Aβ1–42-positive neurons were widespread8 Oxidative Medicine and Cellular Longevity
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Figure 7: The hydrolytic activity of ATPase did not respond
to melatonin. Enzymatic ATP hydrolysis was determined by a
colorimetric reaction measuring the release of free orthophosphate
(Pi), based on the formation of a phosphomolybdate complex in
an acid medium followed by a reduction or complexation with
basic dyes that yield colored complexes. When electron transport
ceases, the inner-membrane potential is developed at the expense
of ATP hydrolysis by the mitochondrial ATP synthase. However,
in the presence of Aβ the hydrolytic activity of ATPase decreases
signiﬁcantly as compared to intact brains (P<0.001) and did not
showanyrecoveryinmelatonin-treatedanimals(fAβ =fAβ +M e l ) ,
which may imply a diﬀerent mechanism of damage by Aβ.I nf a c t ,
another report explores the possibility of a direct interaction of Aβ
with the alpha subunit of the F1Fo-ATP synthase complex [42].
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Figure 8: ROS/mitochondria ratio. The amount of mitochondria
producing free radicals (ROS/mitochondria ratio) is larger in fAβ
and H2O2-injected brains without melatonin treatment, but the
eﬀect is signiﬁcantly reduced by using melatonin.
[67]. These experiments demonstrate the possibility that
extracellular Aβ,e v e ne x o g e n o u sA β1–42, may be the source
of the intraneuronal Aβ. Once inside the neurons, Aβ is
responsible for mitochondrial damages, as we demonstrated.
We have shown in healthy rat brain that following the
intracerebral injection of fAβ1–42, this peptide accumulates
in plaques outside of the cells. There was not another
preexisting pathological condition or predisposition, and
experiments have been carried out under in vivo conditions.
The extracellular accumulation of fAβ1–42 coincided with
axonal degeneration and positive Aβ immunoreactivity
within mitochondria, accompanied by ultrastructural alter-
ations consistent with mitochondrial dysfunction. All of
this also coincide with Saavedra et al. [2] who found that
extracellular Aβ contributes to the intracellular pool of Aβ
and its internalization is not dependent of ApoE, but it is a
lipid raft-mediated mechanism. Additionally, Aβ was shown
to be more eﬃciently internalized by axons than by cell
bodies.
We found, as mentioned before, axonal degenerative
changes with elevated Aβ immunoreactivity (Figure 1). It is
possible that this axonal degeneration could be the origin of
demyelination and a pathway to permit the entry of Aβ into
the neurons via retrograde transport. Previous reports have
revealed increased quantities of Aβ and Aβ1–42 in AD white
matter accompanied by signiﬁcant decreases in the amounts
of myelin basic protein, myelin proteolipid protein, and
2 ,3 -cyclic nucleotide 3 -phosphodiesterase. These observa-
tions suggest that extensive white matter axonal demyeli-
nation underlies Alzheimer’s pathology, resulting in loss of
capacitance and serious disturbances in nerve conduction,
severely damaging brain function [68]. A new hypothesis
suggeststhatmyelinbreakdowninthelate-myelinatingbrain
regionsreleasesiron,whichpromotesthedevelopmentofthe
toxic amyloid oligomers and plaques, which in turn destroy
more myelin [69, 70]( Figure 1). It is worth mentioning that
iron is strongly related to oxidative stress and oxidative stress
is a key protagonist in neurodegenerative diseases [8, 10, 15,
24, 71, 72]. Additionally, we have also found a signiﬁcant
Aβ-induced rearrangement in membrane cholesterol and
fatty acid composition both in cytoplasmic membranes
and in mitochondrial membranes (data not shown), which
culminate with a signiﬁcant alteration in membrane ﬂuidity
(Figure 9).
It is well known that high levels of circulating cholesterol
does not mean high cholesterol concentrations in brain
tissue, essentially because cholesterol in the blood does not
cross the blood brain barrier (BBB). However, hypercholes-
terolemia has certain association with accumulation of Aβ
peptide in brain. The mechanism is not well understood, but
the oxidized cholesterol metabolite 27-hydroxycholesterol
likely plays a key role. Our results (Figures 2 and 9) coincide
with the results from other reports [73–75].
Once the internalization of Aβ and its ability to inﬁltrate
mitochondria were documented, we proceeded to evaluate
the overproduction of mitochondrial free radicals induced
by the presence of Aβ, by using CM-H2XRos, a rosamine
derivative well retained after ﬁxation, which was intraperi-
toneally injected in vivo. This approach allowed us to exam-
ine the free radicals overproduction without changing the
natural architecture of brain tissue or the interrelationship
between cells. Changes in the mitochondrial mass and Aβ-
linked conformational alterations were explored by using
Mitotracker green, applied ex vivo on tissue brain slices.Oxidative Medicine and Cellular Longevity 9
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Figure 9: Aβ reduces mitochondrial membrane ﬂuidity closely related to free radical overproduction and to the respiratory control
ratio. Measured by estimating the excimer to monomer ﬂuorescence intensity ratio (Ie/Im) of DPP, membrane ﬂuidity in mitochondrial
membranes was evaluated in order to show how Aβ, imported from the outside the cell membrane, is able to cause mitochondrial damage
once incorporated within this organelle. We found that the groups producing more free radicals (fAβ and H2O2 groups), showed more
altered membrane ﬂuidity and RCR as compared to PBS-injected brains used as controls (P<0.001). By using melatonin, both membrane
ﬂuidity and RCR were signiﬁcantly ameliorated (fAβ +M e la n dH 2O2 + Mel groups).
Oxidative stress and Aβ toxicity are interdependent
phenomena. In fact, the pathological eﬀects of Aβ heavily
depend on its capacity to provoke oxidative stress [42].
There are two major means by which Aβ induces oxidative
stress, one is through the activation of the NADPH-oxidase
probably both in neurons and in glia [76, 77], which links
redox control and neuroinﬂammatory signaling pathways
[68]. The other means by which Aβ induces oxidative
stress is related to mitochondrial damage, a mechanism
closely linked to apoptosis [78]. Reciprocally, oxidative
stress induces intracellular accumulation of Aβ through
enhancing the amyloidogenic pathway [79]. H2O2 is a well-
known uncoupler of the mitochondrial respiratory activity,
producing a concentration-dependent inhibition of state
3 (ADP-stimulated) respiration and reducing substantially
the ADP:O ratio [80]. An evaluation of electron transport
chain complexes and Krebs cycle enzymes revealed that
alpha-ketoglutarate dehydrogenase, succinate dehydroge-
nase, and aconitase are susceptible to inactivation, which is
a reversible process [81]. Melatonin directly detoxiﬁes H2O2
with the resulting product being N1-acetyl-N2-formyl-5-
methoxykynuramine which is also an eﬃcient free radical
scavenger [81, 82]. For this reason H2O2 was selected as
positive control and the RCR as well as the hydrolytic activity
of ATPase in H2O2-injected brains responded favorably to
melatonin treatment, which implies that oxidative stress may
explain those alterations. However, in fAβ-injected brains,
melatonin had a favorable inﬂuence on the RCR, but it failed
to modulate the ATPase hydrolytic activity. This ﬁnding
explains the energy hypometabolism linked to Aβ, since
ATPase hydrolytic activity is responsible for generating a
proton gradient at the expense of ATP. Interestingly, Aβ is
similar in structure to the ATP synthase-binding sequence
of the inhibitor of F1 (IF1), a naturally occurring inhibitor
of the ATPase activity of the F1Fo-ATP synthase complex
in mitochondria. Thus, as with IF1, Aβ may inhibit ATPase
activity presumably by interacting with the alpha subunit
of the F1Fo-ATP synthase complex [83]. We speculate
that this direct interaction could cause the failure of the
antioxidant therapy to restore the ATPase hydrolytic activity
in fAβ-injected brains. Even though melatonin has been
demonstrated to improve mitochondrial function in both
normal and pathological conditions, this eﬀect is related to
its antioxidant activity.
Melatonin did not seem to have a direct eﬀect on the
ATPase hydrolytic activity. However, this endogenous neuro-
hormone incorporates into mitochondria and may decrease
oxygen consumption concomitantly with its concentration,
inhibiting any increase in oxygen ﬂux in the presence of
an excess of ADP, and reducing the membrane potential,
changes that inhibit the production of O2
•− and H2O2,a s
demonstrated in mouse liver cells [84]. Moreover, by using
melatoninitispossibletomaintaintheeﬃciencyofoxidative
phosphorylation and ATP synthesis, while increasing the
activity of the respiratory complexes (mainly complexes I,
III, and IV) [84]. Melatonin also has proven to be eﬀective
in preventing mitochondrial nitric oxide synthase induction
in parkinsonian mice [85]. However, melatonin also failed
to restore the nitrosative stress-induced failure in the ATPase
hydrolyticactivityinsepticmice[86].Thesedatasuggestthat10 Oxidative Medicine and Cellular Longevity
Aβ-induced mitochondrial alterations, as those described at
early stages in AD before the appearance of amyloid plaques,
are the result of internalization of Aβ.L a t e r ,c o n t i n u o u s
overproduction of amyloid peptide, which induces more
oxidative stress [44] and neuroinﬂammation [55, 87], results
in extracellular plaque formation. Thus, the eﬀects of Aβ on
mitochondria could be an extension of the amyloid cascade.
The results presented here support the hypothesis of the
internalization of Aβ as a major cause of mitochondrial
dysfunction during AD.
ConcludingRemarks. ExtracellulardepositsofAβ may access
mitochondria because of the Aβ ability to permeabilize
cellular membranes and lipid bilayers. Thus, Aβ can pass
through the membranes from outside in the extracellular
space, where these deposits become so huge they form
plaques, visible with conventional microscopy. The role of
Aβ-induced membrane damage and the ability of Aβ to
pass through diﬀerent compartments are fundamental to
understandthemitochondrialenergeticfailure.Alltheabove
mentioned,inacontextwherelipidsandassociatedoxidative
stress play a key role.
4.MaterialsandMethods
4.1. In Vivo Aβ-Injected Model. Surgical and animal care
procedures were performed with strict adherence to the
guide for the care and use of laboratory animals (National
Institutes of Health, publication number 86–23, Bethesda,
MD, USA). All protocols and procedures were approved
by the institution’s Animal Care and Use Committee. Male
Wistar rats (250–280 grams; 3-month-old) were housed in
pairs in a colony room on a 12:12 dark/light cycle with lights
oﬀ at 20:00h; food and water were provided ad libitum.T h e
rats were divided (n = 5) in the following groups: (1) vehicle
(PBS) injected rats, (2) ﬁbrillar Aβ1–42-injected rats (fAβ),
and (3) H2O2 (200μM) intracerebrally injected rats (H2O2).
Two additional groups, fAβ +M e la n dH 2O2 +M e lw e r e
included. In this case, fAβ or H2O2-intracerebrally injected
animals received antioxidant treatment with melatonin
(Sigma, St. Louis, MO, USA), which was dissolved in the
watering vessel at a dose of 20mg/kg/day [24]. H2O2 was
used as a positive control because of its powerful oxidizing
capacity and its particular ability to alter mitochondria
state 3 NADH-linked respiration [88]. The utility of vehicle
s o l u t i o n sa sc o n t r o l sa g a i n s tA β, such as saline solution or
PBS has been well established from published data [89, 90].
Aβ exhibits a chemistry that facilitates the formation of
reactive free radical peptides. It is acceptable to use PBS
insteadofAβpeptidesbecauseevennon-toxicAβderivatives,
notexcludingthescrambledAβ,ausualcontrolinthisinvivo
model,possessalkylsulﬁdeswhichmayreactwithoxygenina
metal-independentmannertoproduceasulfoxide[91].Also,
these derivatives may generate PBN adducts, indicating the
presence of peptide-derived free radical species [72].
Hippocampal injections of Aβ1−42 (2 microliters at a
ﬁnal concentration of 1mM) were performed as previously
described [10, 24, 71]. Lyophilized synthetic Aβ1−42 (Sigma,
St. Louis, MO, USA) peptide was solubilized (10−4M) in
ﬁltered, sterile PBS, then was allowed to incubate with
continuous agitation (Teﬂon stir bar at 800rpm) at 23◦Cf o r
36h[71,92]inordertoformﬁbrillaraggregates.Rats,anaes-
thetizedwithchloralhydrate(350mg/kg,i.p.),wereplacedin
a stereotaxic instrument for the intracerebral injections over
a 5min period (coordinate: anterior-posterior = −3.8mm,
medial-lateral = 2.0mm, dorsal-ventral = 2.6mm from
bregma [93], using 5-microliter Hamilton microsyringe
coupled with a 30 gauge needle through ﬂexible tubing.
The needle was left in place for 5min after injection. The
same coordinates were used for PBS-injected controls and
the H2O2 experimental group.
36 hours after the injections, rats were deeply anes-
thetized and transcardially perfused with 200mL of PBS.
Those animals used for immunohistochemical procedures
wereadditionallyperfusedwith4%paraformaldehyde.Brain
was removed and a piece of tissue (164–180mg), including
the lesioned area, was taken with a punch (diameter 10mm),
at the base of the needle tract. This piece included the
hippocampal tissue and adjacent cortical areas.
4.2. Immunohistochemistry. For Aβ immunohistochemistry,
5mm brain slices were postﬁxed with paraformaldehyde
for 2hr, washed in PBS, and cut into 25–30μm thick
sections with a Vibratome (Leica). Immunohistochemical
staining was carried out using a routine immunoperoxidase
technique on free-ﬂoating sections. Tissue was ﬁrst washed
in 0.05M PBS, then rinsed in 1% H2O2 in PBS, washed in
0.05MPBS,andpreincubatedinPBScontaining0.3%Triton
X-100 (PBST); sections were then incubated overnight at
roomtemperaturewithrabbitanti-Aβ antiserum(anti-βA42,
1:1500, from Santa Cruz) in 0.1% PBST. After 15h, tissue
was washed twice in 0.3% PBST followed by incubation
with a horseradish peroxidase-bound goat anti-rabbit IgG
secondary antibody for 2 hours (Santa Cruz Biotechnology,
Inc.). The tissue was washed in 0.3% PBST, then in PBS,
and then reacted with 3,3 -diaminobenzidine (DAB) (Sigma
Chemical Company).
For the immunoelectron microscopy, hippocampus tis-
sue samples were ﬁxed in 4% paraformaldehyde for 24 hours
and immersed in sucrose in 2.3M for 24 hours. Small blocks
were cut and postﬁxed in osmium tetroxide 2% in PB 0.2M
f o r4 5m i n u t e s ,t h e ne m b e d d e df o r4 8h o u r si nE m b e d8 1 2
(Electron Microscopy Sciences). Ultrathin sections of 70–
90nm were cut with an ultramicrotome (Reichert Om3)
and mounted on nickel grids, then incubated for 2 hours
in 5% BSA and 0.1% ﬁsh gelatin. For immunolabeling
experiment, the mounted sections were then incubated for
2 4h o u r sa t4 ◦C with the primary polyclonal antibody Anti-
Aβ (Santa Cruz Biotechnology) at dilution 1:1000 and then
washed four times with PBS 0.1M and 0.1% tween-20, and
further incubated for 3 hours at room temperature with a
6nm gold-conjugated secondary goat anti-rabbit antibody
(Jackson Immunoresearch Laboratories) at dilution 1:500.
After four washes with PBS, sections were counterstained
with 2% uranyl acetate for 15 minutes and lead citrate for
5 minutes and examined in a Zeiss EM 906 transmission
electron microscope (Oberkochen, Germany).Oxidative Medicine and Cellular Longevity 11
4.3.Diet. Inordertounderlinetheimportanceofcholesterol
in the neuronal Aβ-induced damage, animals intracerebrally
injected with fAβ were divided in two groups, one receive
regularLaboratoryRodentDietchows,whiletheothergroup
was fed with 4% cholesterol-enriched chows plus 1% colic
acid (Harlan Teklan TD. 01418). Images were analyzed by
usingImagePro-Plussoftware(v5.1)andstructuraldamages
were determined as a percentage of the damaged membranes
against complete, healthy mitochondrial membranes per
ﬁeld.
4.4. Analysis of Mitochondrial Free Radical Generation. Mito-
tracker red CM-H2XRos (Molecular Probes), a rosamine
derivative used to detect mitochondrial free radicals, was
diluted in DMSO to form a 1mM stock solution. 100μL
of that solution were diluted in 5mL of saline physiological
solution and stored sterile at 4◦C as working solution.
Applied at a dose of 0.030μg/kg, CM-H2XRos did not aﬀect
thefunctionalpropertiesofmitochondriaafterloading,since
neither respiratory output nor cell viability was signiﬁcant
changed, as evaluated in a separate study (data not shown).
Two hours following the intraperitoneal injection of CM-
H2XRos, animals were perfused transcardially with PBS
followed by 4% paraformaldehyde. The brains were imme-
diately removed and immersed in the ﬁxative for 8–10h.
Following a brief washing in PBS, brain slices were cut into
25–30μm thick sections, including the area of interest, with
the vibratome and incubated free-ﬂoating in MitoTracker
Green (Molecular Probes, Ex/Em 490/516nm), which selec-
tively stains mitochondria both in live cells and in cells
that have been ﬁxed [94]. Then sections were mounted on
adhesive (Vecta Bond)-coated glass slides, with a DNA dye,
4 ,6-diamidino-2-phenylindole (DAPI), containing mount-
ing medium (Vectashield, Vector Laboratories) in order to
evaluate mitochondrial mass in cells with nuclear counter-
staining in blue (Ex/Em 359/461nm). The mitochondrial
free radicals were analyzed by monitoring the oxidized
ﬂuorescence product (Ex/Em 554/576nm) of CMH2XRos
under a ﬂuorescence microscope (Carl Zeiss Axioskop).
Integrated optical density (IOD), number of mitochondria,
as well as its mitochondrial area was determined by using
image analysis software (Image-Pro Plus v5.1).
4.5. Mitochondrial Isolation. Brieﬂy, brain tissue was minced
and placed in prechilled Dounce homogenizer with SHE
buﬀer (0.25M sucrose, 5mM HEPES and 1mM EGTA, PH
7.4), followed by centrifugation at 2500rpm for 10min,
4◦C, recentrifugation of the supernatant (8500rpm, 10min)
obtainacrudemitochondrialpellet,whichinturn,following
a 10min incubation in ice, was resuspended again in SHE
plus delipidized bovine serum albumin (Sigma Chemical
Company). Albumin was eliminated by centrifugation of the
mitochondrial suspension at 9500rpm, 10min. The protein
content in the mitochondrial fraction was determined using
the Lowry method [95].
4.6. Respiratory Control Ratios (RCRs). The measurement of
oxygen consumption ratios was performed at 34◦C using
an incubation chamber with a water jacket and a Clark-type
O2 electrode (Yellow Spring Instrument Co., Yellow Spring,
OH, USA) and the respiratory control ratios calculated
according to Chance and Williams [96]. 1.9mL of air-
saturated KME buﬀer (125mM KCl, 20mM MOPS, 5mM
MgCl and 0.1mM EGTA at pH 7.6) was added to the
chamber and equilibrated with the oxygen electrode for
3min with stirring. Freshly prepared mitochondria (1mg
protein/mL) were then added to the buﬀer in the chamber
and incubated for another 3min with stirring. Respiration
was started by adding 5mM orthophosphate (Pi), 5mM
succinate and 1mM ADP. For oxidation of succinate, small
amounts of ADP stimulated respiratory ratios (State 3) until
ADP became exhausted (State 4). The respiratory control
ratio (RCR) was calculated from the ratio of state 3/state 4
oxygen consumption ratios.
4.7. ATPase Hydrolytic Activity. ATPase activity was mea-
sured at 40◦C in a medium (1mL) containing 125mm
KCl, 40mM MOPS (pH = 8), 3mM MgCl2,p l u s0 . 1m go f
mitochondrial protein, and the reaction was initiated with
40μL of ATP (75mM) and 10 minutes later stopped with
30% trichloroacetic acid. Free orthophosphate (Pi) delivered
f r o mA T Ph y d r o l y s i sw a sm e a s u r e db yac o l o r i m e t r i ca s s a y
at 660nm based on the formation of a phosphomolybdate
complex in an acid medium (after the addition of 3.3%
ammonium molybdate in 3.8N H2SO4 and 10% FeSO4)
followed by a reduction or complexation with basic dyes that
yield colored complexes [97, 98].
4.8. Fluidity Changes of Mitochondrial Membranes. 1,3-di-
pyrenylpropane(DPP)incorporationintomembranesforms
intramolecular excimers depending mainly on the medium
microviscosity and temperature of determination [99].
Membrane ﬂuidity is determined by estimating the excimer
to monomer ﬂuorescence intensity ratio (Ie/Im) of this
ﬂuorescent probe, a quotient that reﬂexes the lateral mobility
of membrane phospholipids [100]. Brieﬂy, mitochondria
were resuspended in Tris-HCl buﬀer (50mM, pH 8) and
then fragmented by sonication for 15 seconds before being
separatedbycentrifugationat13000rpm.Themitochondrial
membrane pellet was resuspended and proteins were mea-
sured using the Lowry method [95]. 0.1mg of mitochondrial
proteins was mixed in a spectroﬂuorometric cell containing
Tris-HCl (20mM, pH 7.5). DPP solution in ethanol of
spectroscopic grade was diluted (0.02mg/mL) and mixed
with membranes given a molar ratio of ﬂuorescent probe to
membrane phospholipids of 1:1400 and the mixtures were
incubated in the darkness for 4 hours at room temperature.
FluorescenceofDPPincorporatedintomembraneswasmea-
sured at 24◦C on a Perkin Elmer ﬂuorescence spectrometer,
LS50B. The ﬂuorophore was excited at 329nm and the
monomer and excimer ﬂuorescence intensities were read at
379 and 480nm, respectively.
4.9. Statistical Analysis. All data are shown as means ± SE
of triplicate experiments. Statistical analysis of the data for
multiple comparisons was performed by two-way ANOVA12 Oxidative Medicine and Cellular Longevity
followed by Student’s t-tests. For a single comparison,
the signiﬁcance of any diﬀerences between means was
determinedbyunpairedt-tests.Thecriterionforsigniﬁcance
was P<0.05 in all statistical evaluations.
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